Dar MM, Gulzar W, Paray AA, Javid MS. Metabolic, neurological and endocrine safety profiles of atypical antipsychotics: focus on quetiapine, olanzapine and risperidone: an updated review. Int J Res Med Sci [Internet]. 2026 Mar. 30 [cited 2026 Apr. 7];14(4):1738-49. Available from: https://www.msjonline.org/index.php/ijrms/article/view/16533